SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

PURPOSE: To determine the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer. PATIENTS AND METHODS: A 2 × 2 factorial design was used to test two hypotheses: (1) that a novel continuous schedule of doxorubicin-cyclophosphamide was s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Budd, George T., Barlow, William E., Moore, Halle C.F., Hobday, Timothy J., Stewart, James A., Isaacs, Claudine, Salim, Muhammad, Cho, Jonathan K., Rinn, Kristine J., Albain, Kathy S., Chew, Helen K., Burton, Gary V., Moore, Timothy D., Srkalovic, Gordan, McGregor, Bradley A., Flaherty, Lawrence E., Livingston, Robert B., Lew, Danika L., Gralow, Julie R., Hortobagyi, Gabriel N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2015
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268253/
https://ncbi.nlm.nih.gov/pubmed/25422488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.3296
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller